OncoDaily
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
OncoDaily
Oct 23, 2023, 17:31 |
Blog
Denis Horgan: Practical policy options to tackling the implementation gap for diagnostics
Denis Horgan, Executive Director from the European Alliance of Personalised Medicine (EAPM), shared a post…
Oct 23, 2023, 17:30 |
Blog
Kelly Shanahan: Sheila Johnson is a clinical trial hero!
Kelly Shanahan, member of the Metastatic Breast Cancer Alliance, shared a post by MBC Alliance…
Oct 23, 2023, 17:28 |
Blog
Jessica Clerc: Recognizing a great NGO often comes down to the quality of its board and team!
Jessica Clerc, Partnership Manager at UICC, shared on LinkedIn: “Recognizing a great NGO often comes…
Oct 23, 2023, 17:21 |
Blog
Tara Frenkl: Navigating the complexities of life after a prostate cancer diagnosis goes beyond the physical
Tara Franklin, Head of Oncology Department at Bayer, shared on LinkedIn: “Navigating the complexities of…
Oct 23, 2023, 17:17 |
Blog
Nigeria on the Path to Cervical Cancer Elimination by Zainab Shinkafi-Bagudu - Medicaid CF Programs
Medicaid CF Programs shared a post on X/Twitter: “HPV Vaccine: Nigeria on the Path to…
Oct 23, 2023, 17:15 |
Insight
María Natalia Gandur Quiroga: Disappointing update from ESMO 23: Christina Gratzke reveals KEYNOTE-991 study results.
Quoting María Natalia Gandur Quiroga on X/Twitter: “Disappointing update from ESMO 23: Christina Gratzke reveals KEYNOTE-991…
Oct 23, 2023, 15:51 |
Blog
Princess Dina Mired: As a mother of a cancer survivor, my heart goes out to all the innocent children in Gazza who now have to wait whilst cancer is ravaging their tiny bodies since there is no more chemotherapy
Oct 23, 2023, 15:40 |
Blog
Erika Hamilton: Not all AEs are equal...
Erika Hamilton shared a post by Hope Rugo on X/Twitter: “Not all AEs are equal…
Oct 23, 2023, 15:35 |
Blog
Julien Mazières: Alectinib is the first ALK inhibitor to significantly improve DFS compared with CT
Julien Mazières, Thoracic Oncology Specialist at Toulouse University Hospital, France, shared insights from the ALINA…
Oct 23, 2023, 15:26 |
Insight
Tom Powles: Enfortumab vedotin and Pembrolizumab improving PFS and OS by 55% and 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%)
Tom Powles, Director of Barts Cancer Centre, shared on Twitter: "Enfortumab vedotin and Pembrolizumab improving…
Oct 23, 2023, 15:24 |
Insight
Why radiotherapy with concomitant chemotherapy is an excellent option for bladder preservation in bladder cancer patients
Pierre Blanchard, Full Professor of Radiation Oncology at Gustave Roussy Cancer Center, posted on his…
Oct 23, 2023, 15:23 |
Drugs
Pashtoon Kasi: So excited to move the field forward with novel therapies for patients with pMMR/MSS Colorectal Cancer
Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine and NewYork-Presbyterian Hospital, shared on his Twitter:…
Oct 23, 2023, 13:31 |
Drugs
At ESMO 2023 Dr. Breelyn Wilky presented new data from our investigational botensilimab/balstilimab combination in relapsed/refractory sarcoma
Agenus shared on their LinkedIn page: "At ESMO 2023 Dr. Breelyn Wilky presented new data from our investigational…
Oct 23, 2023, 13:26 |
Insight
Marcelo Corassa: Great presentation by the amazing Jarushka Naidoo on the promises and pitfalls of neoadjuvant therapy for NSCLC
Marcelo Corassa, Medical oncologist and Clinical Researcher at Beneficência Portuguesa de São Paulo, shared on…
Oct 23, 2023, 13:21 |
Career
Florian Lordick: Honoured having received the FESMO award from ESMO President Andres Cervantes
Florian Lordick, Professor of Medicine and Director of the University Cancer Center Leipzig, shared on…
Oct 23, 2023, 13:15 |
Drugs
Pashtoon Kasi: We should drop the modified nomenclature and just agree on just dosing schema for FOLFIRINOX
Quoting Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine, on X/Twitter: ''ESMO23 Moving forward…
Oct 23, 2023, 13:07 |
Blog
João Mouta: The most awaited talk for me at ESMO2023
Quoting João Mouta, Principal Global Medical Leader - Breast and Gynecological Cancers at Roche, on…
Oct 22, 2023, 22:00 |
Blog
Ria Freydberg: The dedication and inspiration of these humans is humbling
Ria Freydberg, Executive Director at The Leukemia & Lymphoma Society, made the following post on…
Oct 22, 2023, 21:26 |
Blog
Evelyn Wong: Microbiome or the oncologists - why do Germans do FLOT better!
Evelyn Wong, Associate Consultant, Division of Medical Oncology at the National Cancer Centre Singapore, made…
Oct 22, 2023, 18:13 |
Blog
Save the date for "Deconstructing papers" webinar hosted by Guillermo Chantada - Programa TELEO
Programa TELEO shared on their LinkedIn page: ''If you are interested in research and want…
Oct 22, 2023, 18:11 |
Insight
Katrina Pedersen: Not many people realize that there is NO prospective interventional trial data for FOLFIRI or for a powered Taxane cohort in Small Bowel Adenocarcinoma
Katrina Pedersen, Gastrointestinal Oncologist at Siteman Cancer Center, shared a post by SWOG Cancer Research…
Oct 22, 2023, 18:06 |
Blog
Tahera Bandali: Here at Macmillan Cancer Support we're committed to ensuring we're more actively partnering with people with lived experiences to shape our future with us
Oct 22, 2023, 18:02 |
Blog
Wafik S. El-Deiry: My career citations are coming up on 100,000 in Google Scholar with h-index of 127
Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, recently…
Oct 22, 2023, 17:56 |
Blog
Anna Clemens: Use this template for abstracts and save yourself hours
Quoting Anna Clemens, Founder and CEO of Researchers' Writing Academy, on X/Twitter: ''Are you and…
Oct 22, 2023, 17:46 |
Blog
COA Vice President Debra Patt testified in front of the House Energy and Commerce Committee today on improving patient access to care and cutting red tape for doctors
Community Oncology Alliance recently shared on their LinkedIn page: ''COA Vice President Debra Patt of…
Oct 22, 2023, 17:42 |
Blog
Jerry Ndumbalo: Advancement in Oncology, Honoring excellence, and Global impact at ESMO 2023
Jerry Ndumbalo, President of Tanzania Oncology Society(TOS), shared on LinkedIn: "ESMO 2023: Advancement in Oncology,…
Oct 22, 2023, 17:36 |
Blog
What is the current status of real-world evidence (RWE) in oncology? - ESMO
ESMO (European Society for Medical Oncology) shared on LinkedIn: "What is the current status of…
Oct 22, 2023, 17:28 |
Career
Susana Banerjee: Honoured to receive fellow ESMO (FESMO) award ESMO2023
Susana Banerjee, Professor in Women's Cancers at The Institute of Cancer Research, shared on X/Twitter:…
Oct 22, 2023, 17:22 |
Blog
Giulio Draetta: Tremendously proud of Tina Cascone for her presentation at the 2023 ESMO meeting presidential session
Giulio Draetta, Chief Scientific Officer at The University of Texas M.D. Anderson Cancer Center, shared…
Oct 22, 2023, 17:15 |
Blog
Advanced Oncology discussed the humanitarian crisis linked to the invasion of Artsakh with Davit Zohrabyan
Advanced Oncology shared a post on LinkedIn: “At such a big meeting like ESMO 2023…
Oct 22, 2023, 17:06 |
Insight
Julia Hoveyan: The first comprehensive analysis of pediatric and young adult CNS tumors in Armenia over the last 26 years.
Julia Hoveyan, Paediatric Oncologist at Paediatric Cancer and Blood Disorders Centre of Armenia, shared a…
Oct 22, 2023, 17:00 |
Blog
Ravindran Kanesvaran: Great start to ESMO 2023 day 1!
Ravindran Kanesvaran, Deputy Chair and Senior Consultant, Division of Medical Oncology at National Cancer Centre…
Oct 22, 2023, 16:53 |
Blog
Emrullah Yilmaz: Thank you, ACS CAN, for organising the Ohio Policy Forum at the Statehouse
Emrullah Yilmaz, Director of Precision Oncology at Cleveland Clinic, shared on LinkedIn: “Thank you American…
Oct 22, 2023, 14:50 |
Blog
Nils Nicolay: The first data from our randomized APCOT trial
Nils Nicolay, Chair of the Department of Radiation Oncology at the University of Leipzig Medical…
Oct 22, 2023, 14:43 |
Blog
Martine Zimmermann: She is back to running races and we are celebrating life. She is my hero!
Quoting Martine Zimmermann, Head of Global Regulatory affairs and Research and Development Quality at Ipsen,…
Oct 22, 2023, 14:32 |
Blog
Stacy Hurt: Due to caregiving for Emmett, I never thought I’d see Europe
Stacy Hurt, Patient Advocacy Ambassador at Parexel, shared on LinkedIn: Due to caregiving for Emmett,…
Oct 22, 2023, 14:28 |
Blog
Roupen Odabashian: I can't stop using ChatGPT or AI to delegate mentally draining tasks to it
Roupen Odabashian, Hematology and Oncology Fellow at Karmanos Cancer Institute, shared on LinkedIn: "Many people…
Oct 22, 2023, 14:22 |
Blog
Myriam Chalabi: Honored to receive the Jose Baselga fellowship
Myriam Chalabi posted on her Twitter page: "Day 3 of ESMO23: early start heading to the…
Oct 22, 2023, 14:17 |
Blog
Runcie C.W. Chidebe: My message to many global cancer leaders at the 2023 World Cancer Leaders’ Summit
Runcie C.W. Chidebe, Executive Director at Project PINK BLUE, shared a post on LinkedIn, saying:…
Oct 22, 2023, 14:09 |
Blog
Marlene Thomas: I am particularly excited this year as Roche will be sharing data that is close to my heart!
Marlene Thomas, Head of CGP Portfolio Strategy Roche, shared a post on LinkedIn: "ESMO is…
Oct 22, 2023, 14:08 |
Blog
Diogo Martins Branco: Brain Storm is an investigator-initiated prospective clinical study
Diogo Martins Branco, Board Member at AICSO, shared a post on LinkedIn: "Improving outcomes of…
Oct 22, 2023, 00:11 |
Blog
Maite Bourlon: Press release on CheckMate-67T study of subcutaneous Nivolumab while The European Society for Medical Oncology (ESMO) begins
Maite Bourlon, Urology Oncologist at the National Institute of Medical Sciences and Nutrition Salvador Zubirán,…
Oct 22, 2023, 00:00 |
Blog
Gustaf Salford: We have received a major order of multiple linac systems from Ukraine through our partnership with the Ukrainian Ministry of Health
Gustaf Salford, President and CEO at Elekta, shared the following post by Elekta, adding the following: "This…
Oct 21, 2023, 23:53 |
Blog
Peter Lebowitz: Three Phase 3 lung cancer readouts in the Presidential Symposium and 4 late-breaker presentations in genitourinary cancers
Peter Lebowitz, SVP, Global Oncology Therapeutic Area Head at Janssen/Johnson and Johnson, made the following…
Oct 21, 2023, 23:44 |
Blog
Janice Cowden: We marched on Capitol Hill with Metavivor Research and Support Inc. to advocate for increased funding for Metastatic Breast Cancer
Janice Cowden, Metastatic Breast Cancer Patient Advocate, made the following post on LinkedIn "This week…
Oct 21, 2023, 19:39 |
Blog
Nirmala Bhoo Pathy: A prerequisite to putting patients at the heart of cancer care is knowing what they need
Nirmala Bhoo Pathy, Professor of Epidemiology at the University of Malaya, shared on her LinkedIn…
Oct 21, 2023, 19:38 |
Blog
Top 5 Prostate abstracts not to miss by Tian Zhang
Tian Zhang, Associate Professor specialized in GU cancers at the UT Southwestern Medical Center, shared…
Oct 21, 2023, 19:37 |
Blog
Amol Akhade: Do we need to study every new IO drug against Pembrolizumab plus chemo in first line NSCLC? NO.
Amol Akhade, Senior Consultant in Medical and Hematooncology at the Dr Hitendra Patil's Suyog Cancer…
Oct 21, 2023, 19:37 |
Blog
Jose Fernando Moura: Phase 2 PERLA trial shows a new option in same setting NSCLC 1st line.
Jose Fernando Moura, Oncologist and Principal Investigator in Solid Tumors at Real Hospital Portuguese and…
Oct 21, 2023, 19:36 |
Blog
Nicola Fusco: It has been a genuine pleasure to visit the Institute Gustave Roussy
Nicola Fusco shared a post on LinkedIn: “It has been a genuine pleasure to visit…
Oct 21, 2023, 19:35 |
Blog
Yuki Nishida: It was such an honor that I was able to introduce our recent work on p53/MDM2 and mutant p53.
Yuki Nishida, Instructor at MD Anderson Cancer Centre, shared on LinkedIn: “It was such an…
Oct 21, 2023, 19:29 |
Blog
New EORTC 2129-BCG TREAT ctDNA study on Early-Stage Breast Cancer in collaboration with MENARINI Group
EORTC - European Organisation for Research and Treatment of Cancer shared on LinkedIn, “On Breast…
Oct 21, 2023, 19:24 |
Opinion
Olubukola Ayodele: Day 1 of ESMO 2023 was all about early breast cancer (EBC) for me today
Olubukola Ayodele, Consultant Medical Oncologist at University Hospitals of Leicester NHS trust, shared on LinkedIn:…
Oct 21, 2023, 19:19 |
Blog
Akash Maniam: Personally, the neoadjuvant IO data in early breast cancer is the most intriguing
Akash Maniam, a Medical Oncologist at Portsmouth Hospitals University NHS Trust, and the Clinical Director…
Oct 21, 2023, 19:13 |
Career
Melvin LK Chua: What a lecture East meets West by Prof Anthony Chan
Melvin LK Chua, Head of Department of Head Neck and Toracic Cancers, Division of Radiation…
Oct 21, 2023, 19:09 |
Societies
Evandro de Azambuja: We are over 34,000 members at ESMO
Evandro de Azambuja, ESMO Director of Membership 2023-2024, shared on his Twitter: "As the ESMO…
Oct 21, 2023, 19:04 |
Insight
Sharlene Gill's summary of KEYNOTE-811 by Yelena Janjigian from ESMO23
Sharlene Gill shared on her Twitter: " KN811 Yelena Janjigian: ph3 HER2+ mG/GEJc chemo + trastuzumab +/-…
Oct 21, 2023, 19:00 |
Blog
Yelena Janjigian: A new treatment for patients with HER2+ gastroesophageal cancer in Europe, US and Brazil
Yelena Janjigian posted on her LinkedIn: "From preclinical rationale to our Memorial Sloan Kettering Cancer Center…
Oct 21, 2023, 18:55 |
Stories
Mark Lewis: I cannot abide this cowardly callousness by another doctor who must know that delays can cause real harm
Quoting Mark Lewis on X/Twitter: “NEW INSURANCE TACTIC JUST DROPPED! A 'peer' reviewer approved a…
Oct 21, 2023, 16:08 |
Stories
Ani Haykuni: My story isn’t about sadness or fear
Ani Haykuni, Founder and CEO of Vann, shared on LinkedIn: “October is the breast cancer…
Oct 21, 2023, 14:10 |
Career
H. Jack West: I joined Summit Therapeutics as Vice President of Clinical Development!
H. Jack West, Vice President of Clinical Development at Summit Therapeutics, Inc, shared a post…
Oct 21, 2023, 14:09 |
Blog
Rachna Shroff: So excited to lead University of Arizona COM - Division of Hematology and Oncology
Rachna Shroff shared a post on Twitter: "The cat is finally out of the bag…so excited…
Oct 21, 2023, 14:04 |
Drugs
Tom Powles: Renal cancer highlights ESMO23
Tom Powles Director of Barts Cancer Centre, shared a post on LinkedIn, saying: "Renal cancer…
Oct 21, 2023, 13:59 |
Societies
ESMO 2023 Social Media Ambassadors - European Society for Medical Oncology
Quoting the European Society for Medical Oncology on LinkedIn: "The Society is pleased to announce…
Oct 21, 2023, 13:52 |
Blog
Milen Minkov: A highlight of the meeting was the Dr.h.c. Ceremony
Milen Minkov, Head of Pediatric Oncology at Kepler University Hospital, Johannes Kepler University, Linz, recently…
Oct 21, 2023, 13:43 |
Blog
Maggie Powell: About volunteering for the American Cancer Society Cancer Action Network
Maggie Powell, Volunteer for Lake County 19th Judicial Circuit - Veteran's Treatment and Assistant Court,…
Oct 21, 2023, 13:39 |
Opinion
Jason A. Mouabbi: Join me with Keira Smith to debunk common myths about breast cancer
Jason A. Mouabbi, Chair of Lobular Breast Cancer Alliance, recently tweeted: "October is Breast Cancer…
Oct 21, 2023, 09:29 |
Blog
15 Posts From the World Cancer Leaders Summit 2023 Not To Miss!
The World Cancer Leaders' Summit 2023 took place on 16th and 17th of October in…
Oct 21, 2023, 07:58 |
Stories
The story of the world largest childhood cancer center and its founder Dr Sherif Abouelnaga, by Ahmed Kamal Bayoumi
By Ahmed Kamal Bayoumi, SIOP member , Senior clinical specialist, CCHE 57357 Egypt Dr Abouelnaga…
Oct 20, 2023, 23:03 |
Blog
Crystal Denlinger: NCCN Global Academy for Excellence and Leadership in Oncology
Crystal Denlinger, Chief Executive Officer at National Comprehensive Cancer Network, made the following post on…
Oct 20, 2023, 22:56 |
Blog
Tracey O’Brien: Cancer Institute NSW has funded $300,000 to train 200 midwives and 50 Aboriginal health workers on the Cervical Screening Test’s self-collection option
Oct 20, 2023, 22:45 |
Blog
Dr. Mina Sedrak received a 5-year, $3.4 million grant from the NIH - Department of Medicine at UCLA Health
Department of Medicine at UCLA Health, made the following post on Twitter: "Congratulations to Dr.…
Oct 20, 2023, 20:21 |
Blog
Jason Westin: Dr. Bertagnolli is an excellent choice to lead National Institute of Health at this critical time.
Jason Westin, Director of Clinical Research at MD Anderson Cancer Centre, shared a post by…
Oct 20, 2023, 20:21 |
Blog
Beri Ridgeway: Dr. Abraham is not only an expert in his field, but also a compassionate leader and team member
Quoting Beri Ridgeway, Chief Of Staff at Cleveland Clinic, on LinkedIn: "I am thrilled to…
Oct 20, 2023, 20:20 |
Blog
Perry Wilson: AI in Medicine is suffering from what I would like to call "The Cassandra Problem"
Quoting Perry Wilson, Director, Clinical and Translational Research Accelerator at Yale University, on X/Twitter: "AI…
Oct 20, 2023, 20:19 |
Blog
Nina Mojas: Events like ESMO23 provide important opportunities to come together and find potential solutions to the challenges faced by patients
Nina Mojas, Senior Vice President of Oncology at GSK, recently shared on LinkedIn: "As we…
Oct 20, 2023, 20:19 |
Blog
Gauri Sunkersett: Honored to have been invited to The Leukemia and Lymphoma Society Dare to Dream Summit in Washington, D.C.
Gauri Sunkersett, Medical Director at AbbVie One Oncology, recently posted on LinkedIn: "Honored to have…
Oct 20, 2023, 20:18 |
Blog
Thank you to everyone who made this summit a success! - Union for International Cancer Control (UICC)
Union for International Cancer Control (UICC) shared the following on LinkedIn: "The World Cancer Leaders'…
Oct 20, 2023, 20:17 |
Stories
Ali Divan: After 7 years in academia, I had lost my sense of purpose and confidence...
Ali Divan, Founder and Principal of Trulitica, recently shared a post on LinkedIn, saying: "After…
Oct 20, 2023, 20:16 |
Societies
Watch any of the sessions from SIOP congress again - POINTE
POINTE (Pediatric Oncology International Network for Training & Education) posted on X/Twitter: "This is the…
Oct 20, 2023, 20:15 |
Blog
Alexander Sherry: P values have no place in the Table 1 of oncology RCTs
Alexander Sherry, Radiation Oncologist at MD Anderson Cancer Center, posted on his Twitter: "P values…
Oct 20, 2023, 20:14 |
Career
Aleksandra McNee: I have joined the amazing team at Waverley Private Hospital as CEO
Aleksandra McNee, Chief Executive Officer at the Ramsay Health Care, announced on her LinkedIn: " I…
Oct 20, 2023, 20:13 |
Insight
Aman Chauhan: We will continue to work on NEC and SCLC and hopefully find a breakthrough
Aman Chauhan, Leader of Neuroendocrine Cancer Program at the Sylvester Comprehensive Cancer Center, shared on his…
Oct 20, 2023, 20:12 |
Career
Alyssa Kennedy's new position as an Assistant Member at St. Jude Children's Research Hospital
Alyssa Kennedy, Assistant Member at St. Jude Children's Research Hospital, shared a post on LinkedIn:…
Oct 20, 2023, 20:12 |
Insight
Vanina Laurent-Ledru: 4 key take-aways from the session on implementing One Health at the World Health Summit in Berlin
Vanina Laurent-Ledru, Director General at Foundation S- The Sanofi Collective, shared a post on LinkedIn:…
Oct 20, 2023, 20:08 |
Blog
Tune in to hear about Barriers to Technology Use - President's Cancer Panel
President's Cancer Panel shared a post on Twitter, announcing: "We are now on session three of…
Oct 20, 2023, 20:06 |
Insight
Nina Niu Sanford: Our work on clinical trial endpoints and inclusion criteria in GI oncology trials
Nina Niu Sanford, Chief of Gastrointestinal Radiation Oncology Service at UT Southwestern Medical Center, shared…
Oct 20, 2023, 20:02 |
Insight
10 ESMO23 breast cancer abstracts not to miss by Paolo Tarantino
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on Twitter: "ESMO23 will have…
Oct 20, 2023, 19:58 |
Stories
The work Rosenthal had done to annotate CT scans of patients with pancreatic cancer and more by Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn: "As a cancer imaging fellow at Dana-Farber, Michael Rosenthal,…
Oct 20, 2023, 19:54 |
Blog
Celine Surmont-Francina: The World Cancer Leaders Summit 2023 resumed today
Celine Surmont-Francina, Head of Congress and Events at Union for International Cancer Control, shared a…
Oct 20, 2023, 19:53 |
Blog
We’re launching a new Biohub in New York to harness immune cells to better detect, prevent and treat disease - Chan Zuckerberg Initiative
Chan Zuckerberg Initiative, shared a post on LinkedIn, saying: "We’re excited to announce that we’re…
Oct 20, 2023, 19:52 |
Blog
David Kavanagh: Global burden of lung cancer incidence for the four main histological subtypes
David Kavanagh, Head of the Human Resources Office at the International Agency for Research on…
Oct 20, 2023, 19:47 |
Blog
Nicholas Vitanza: Thank you, Society of Research Administrators International
Nicholas Vitanza, Pediatric neuro-oncologist at Seattle Children's Hospital, shared on X/Twitter: "Thank you, Society of…
Oct 20, 2023, 19:40 |
Blog
Ed Kim: This is for all the dedicated nurses who walk alongside their patients every day
Quoting Ed Kim, Physician-in-Chief at the City of Hope, shared on LinkedIn: "When my father,…
Oct 20, 2023, 17:15 |
Dialogues
Leadership lessons from the SIOP President Guillermo Chantada, Hosted by Ruzanna Papyan
OncoDaily had the honor of speaking with SIOP President, Dr. Guillermo Chantada. Despite his busy…
Oct 19, 2023, 22:20 |
Blog
Guillermo Chantada: The long controversy about the management of choroidal invasion
Guillermo Chantada, President of SIOP, shared a post by Hospital Sant Joan de Déu Barcelona, on…
Oct 19, 2023, 22:08 |
Blog
Dr. Layth Mula-Hussain, recently joined the ICC board of directors - The Institute of Cancer and Crisis (ICC)
The Institute of Cancer and Crisis (ICC), made the following post on LinkedIn: "We are…
Oct 19, 2023, 19:04 |
Blog
Senate HELP Committee held a hearing on NCI Director Monica Bertagnolli's nomination to lead The National Institutes of Health - American Cancer Society Cancer Action Network
Oct 19, 2023, 19:04 |
Blog
Isabel Mestres: You can now Take Your City Further with City Cancer Challenge
Isabel Mestres, CEO at City Cancer Challenge Foundation, shared a post on LinkedIn, saying: "Hot…
Oct 19, 2023, 19:03 |
Blog
Karen Knudsen: Check out Dr. Wayne A.I. Frederick at the The Washington Post talking about disparities in cancer
Karen Knudsen shared a post on LinkedIn, saying: "ICYMI, check out American Cancer Society Board member…
138
139
140
141
142
All:
16186
Posts:
13901 - 14000
Why does Lionel Messi donate so much to charity?
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Facebook
RSS Feed
Twitter
Linkedin
Youtube